(Methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses

Details for Australian Patent Application No. 2010333767 (hide)

Owner Celgene Corporation

Inventors Schafer, Peter H.; Frank, Anthony J.; Man, Hon-Wah; Shankar, Sai L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010333767

PCT Pub. Number WO2011/079091

Priority 61/289,356 22.12.09 US

Filing date 21 December 2010

Wipo publication date 30 June 2011

International Classifications

C07D 209/46 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/403 - condensed with carbocyclic rings, e.g. carbazole

A61P 17/00 Drugs for dermatological disorders

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 Antineoplastic agents

C07D 407/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/079091 Priority application(s): WO2011/079091

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010333769-Method and device for visual compensation

2010333764-Improved external nasal dilator